J. O’Shaughnessy

667 total citations
11 papers, 512 citations indexed

About

J. O’Shaughnessy is a scholar working on Oncology, Molecular Biology and Dermatology. According to data from OpenAlex, J. O’Shaughnessy has authored 11 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Dermatology. Recurrent topics in J. O’Shaughnessy's work include Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). J. O’Shaughnessy is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). J. O’Shaughnessy collaborates with scholars based in United States and United Kingdom. J. O’Shaughnessy's co-authors include Douglas M. Fast, Daniel Tang, Marian Kelley, Anthony J. DeStefano, Russell Weiner, Shang‐Ying P. King, C.T. Viswanathan, Ajai K. Chaudhary, Andrea Denicoff and Marianne Noone and has published in prestigious journals such as Science, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

J. O’Shaughnessy

11 papers receiving 476 citations

Peers

Countries citing papers authored by J. O’Shaughnessy

Since Specialization

Citations

This map shows the geographic impact of J. O’Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. O’Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. O’Shaughnessy more than expected).

Fields of papers citing papers by J. O’Shaughnessy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. O’Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. O’Shaughnessy. The network helps show where J. O’Shaughnessy may publish in the future.

Co-authorship network of co-authors of J. O’Shaughnessy

This figure shows the co-authorship network connecting the top 25 collaborators of J. O’Shaughnessy. A scholar is included among the top collaborators of J. O’Shaughnessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. O’Shaughnessy. J. O’Shaughnessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Advancing alternative methods to reduce animal testing 2024 ·Science ·(unknown), Paul C. Brown, Suzanne Fitzpatrick, Kevin A. Ford, Paul C. Howard, (unknown), (unknown), J. O’Shaughnessy, Tucker A. Patterson, (unknown), Rodney Rouse, (unknown), Kyung E. Sung, Luis G. Valerio, Jeffrey L. Ward, (unknown)	9
2	Abstract OT2-07-05: A phase III, randomized trial of sacituzumab govitecan (IMMU-132) vs treatment of physician choice (TPC) for metastatic triple-negative breast cancer (mTNBC) 2018 ·Cancer Research ·(unknown), HS Rugo, Heather Horne, (unknown), D M Goldenberg, J. O’Shaughnessy	2
3	Center for Drug Evaluation and Research Perspective on Quality in Clinical Trials 2017 ·Therapeutic Innovation & Regulatory Science ·(unknown), J. O’Shaughnessy, Janet Woodcock	1
4	Workshop Report and Follow-Up—AAPS Workshop on Current Topics in GLP Bioanalysis: Assay Reproducibility for Incurred Samples—Implications of Crystal City Recommendations 2009 ·The AAPS Journal ·Douglas M. Fast, Marian Kelley, C.T. Viswanathan, J. O’Shaughnessy, Shang‐Ying P. King, Ajai K. Chaudhary, Russell Weiner, Anthony J. DeStefano, Daniel Tang	208
5	Gemcitabine plus paclitaxel (GT) versus paclitaxel (T) as first-line treatment for anthracycline pre-treated metastatic breast cancer (MBC): Quality of life (QoL) and pain palliation results from the global phase III study 2004 ·Journal of Clinical Oncology ·Carol M. Moinpour, (unknown), Gary Donaldson, Astra M. Liepa, Allen S. Melemed, J. O’Shaughnessy, Erica Rappold, Kathy S. Albain	37
6	Survival benefit with Xeloda (capecitabine)/docetaxel vs docetaxel: analysis of post-study therapy. 2001 ·Breast Cancer Research and Treatment ·David Miles, (unknown), J. O’Shaughnessy, Guadalupe Cervantes, Björn Erikstein, M Findlay, Vera Gorbounova, Shulamith Rizel, S. Verma, Svetislava J. Vukelja	12
7	Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients. 1996 ·Journal of Clinical Oncology ·Anthony W. Tolcher, Kenneth H. Cowan, Marianne Noone, Andrea Denicoff, David Köhler, Barry R. Goldspiel, (unknown), Mary S. McCabe, (unknown), Jo Anne Zujewski, J. O’Shaughnessy	26
8	The Effects of Phenobarbital Pretreatment on the Metabolism and Toxicity of Paraoxon in the Mouse 1995 ·Pharmacology & Toxicology ·(unknown), J. O’Shaughnessy, Lester G. Sultatos	8
9	Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. 1995 ·PubMed ·Lalage M. Wakefield, John J. Letterio, (unknown), David Danielpour, R. S. Allison, Lee H. Pai, Andrea Denicoff, Marianne Noone, Kenneth H. Cowan, J. O’Shaughnessy	139
10	Interaction of ethanol and the organophosphorus insecticide parathion 1995 ·Biochemical Pharmacology ·J. O’Shaughnessy, Lester G. Sultatos	10
11	Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. 1991 ·Journal of Clinical Oncology ·J. O’Shaughnessy, R. Wittes, Gerard Burke, Moshe Friedman, John R. Johnson, John E. Niederhuber, M.L. Rothenberg, Janet Woodcock, B A Chabner, R Temple	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact